246 related articles for article (PubMed ID: 30175528)
1. Reward-enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention-deficit/hyperactivity disorder.
Ide S; Ikekubo Y; Hua J; Takamatsu Y; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacol Rep; 2018 Sep; 38(3):149-153. PubMed ID: 30175528
[TBL] [Abstract][Full Text] [Related]
2. Distinct Roles of Opioid and Dopamine Systems in Lateral Hypothalamic Intracranial Self-Stimulation.
Ide S; Takahashi T; Takamatsu Y; Uhl GR; Niki H; Sora I; Ikeda K
Int J Neuropsychopharmacol; 2017 May; 20(5):403-409. PubMed ID: 28031268
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of dopamine transporter knockout mice as an animal model of AD/HD].
Kasahara Y; Kubo Y; Sora I
Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):185-9. PubMed ID: 25069256
[TBL] [Abstract][Full Text] [Related]
4. Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths.
Leddy JJ; Waxmonsky JG; Salis RJ; Paluch RA; Gnagy EM; Mahaney P; Erbe R; Pelham WE; Epstein LH
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):127-36. PubMed ID: 19364291
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
[TBL] [Abstract][Full Text] [Related]
6. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
[TBL] [Abstract][Full Text] [Related]
7. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
[TBL] [Abstract][Full Text] [Related]
8. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
[TBL] [Abstract][Full Text] [Related]
9. The effects of methylphenidate on knockin mice with a methylphenidate-resistant dopamine transporter.
Tilley MR; Gu HH
J Pharmacol Exp Ther; 2008 Nov; 327(2):554-60. PubMed ID: 18698001
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
Roman T; Rohde LA; Hutz MH
Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031
[TBL] [Abstract][Full Text] [Related]
11. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.
Faraone SV
Neurosci Biobehav Rev; 2018 Apr; 87():255-270. PubMed ID: 29428394
[TBL] [Abstract][Full Text] [Related]
12. Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.
Mergy MA; Gowrishankar R; Davis GL; Jessen TN; Wright J; Stanwood GD; Hahn MK; Blakely RD
Neurochem Int; 2014 Jul; 73():56-70. PubMed ID: 24332984
[TBL] [Abstract][Full Text] [Related]
13. Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter.
Takamatsu Y; Hagino Y; Sato A; Takahashi T; Nagasawa SY; Kubo Y; Mizuguchi M; Uhl GR; Sora I; Ikeda K
Curr Mol Med; 2015; 15(3):245-52. PubMed ID: 25817856
[TBL] [Abstract][Full Text] [Related]
14. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).
Vles JS; Feron FJ; Hendriksen JG; Jolles J; van Kroonenburgh MJ; Weber WE
Neuropediatrics; 2003 Apr; 34(2):77-80. PubMed ID: 12776228
[TBL] [Abstract][Full Text] [Related]
15. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain.
Volkow ND; Wang GJ; Fowler JS; Telang F; Maynard L; Logan J; Gatley SJ; Pappas N; Wong C; Vaska P; Zhu W; Swanson JM
Am J Psychiatry; 2004 Jul; 161(7):1173-80. PubMed ID: 15229048
[TBL] [Abstract][Full Text] [Related]
16. [Neuropsychopharmacological effects of methylphenidate].
Ikeda K; Takamatsu Y; Hagino Y; Sora I
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Jun; 29(3):121-3. PubMed ID: 19663262
[TBL] [Abstract][Full Text] [Related]
17. A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.
del Campo N; Fryer TD; Hong YT; Smith R; Brichard L; Acosta-Cabronero J; Chamberlain SR; Tait R; Izquierdo D; Regenthal R; Dowson J; Suckling J; Baron JC; Aigbirhio FI; Robbins TW; Sahakian BJ; Müller U
Brain; 2013 Nov; 136(Pt 11):3252-70. PubMed ID: 24163364
[TBL] [Abstract][Full Text] [Related]
18. [Neuropsychiatric bases of the methylphenidate-therapy of the attention deficit/hyperactivity disorder (ADHD)].
Huber M; Kirchler E; Niederhofer H; Gruber L
Fortschr Neurol Psychiatr; 2007 May; 75(5):275-84. PubMed ID: 17443438
[TBL] [Abstract][Full Text] [Related]
19. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
Wilens TE
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
[TBL] [Abstract][Full Text] [Related]
20. Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder.
Russell V; de Villiers A; Sagvolden T; Lamm M; Taljaard J
Behav Brain Res; 1998 Jul; 94(1):163-71. PubMed ID: 9708847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
